Increasing understanding of the physicochemical properties, primary structure and function of antibody molecules has demonstrated that immunoglobulins show incredible diversity. How such diversity is generated within the individual has posed a challenge to genetic dogma. The major questions to be answered are (a) how many genes are required to code for all possible immunoglobulins; (b) are the necessary genes inherited; (c) do new genes arise by a process of somatic recombination or are there relatively few antibody genes in the germ-line which are diversified by somatic mutational events? The contribution of modern research to an understanding of the generation of antibody diversity and the genetic control of immunoglobulin synthesis was discussed at this meeting.
Dr A Munro (Department of Pathology, University of Cambridge) introduced the meeting with a short review of the structure of the immunoglobulin molecule. Electron microscopy studies (Feinstein & Rowe 1965) have indicated that the monomeric immunoglobulin molecule is Yshaped. The tail of the Y can be cleaved by pepsin digestion and represents the Fc portion, while the two arms represent the Fab fragments (Porter 1959) . The two antigen-combining sites are identical and occur in the terminal portions of the Fab arms. The Fc and Fab portions are joined by a hinge region, which gives flexibility to the molecule in certain classes. By reductive cleavage of human IgG myeloma globulin, two kinds of polypeptide chains are obtained (Edelman & Poulik 1961) . The larger is called the heavy or H chain and the smaller the light or L chain. An immunoglobuin molecule consists of 2H and 2L chains joined by disulphide bridges. There are five classes of H chain (a, y, p, (, e) and two types of light chain (K and A). In any single molecule both heavy chains are of the same class and both light chains of the same type. Both heavy and light chains are made up of homology regions or domains of about 110 amino acid residues. There are two domains in each light chain, a variable (VL) region comprising the first 110-120 amino acid residues at the amino terminus and a constant (CL) region. There are four domains in the y, ox, and ( chains, one VH and three CH, and in the i and £ chain the hinge region is replaced by a complete fifth domain (C4). Within each domain there is a loop of some 60 amino acid residues formed by an intra-chain disulphide bond. The amino acid sequence in the variable region, wherein is found the antigenbinding site, is critical for the specificity of the immunoglobulin.
The basic structure of the monomeric unit described is common to all immunoglobulins (IgG, IgA, IgM, IgD and IgE); however IgA can occur as a dimer, particularly in secretions, and IgM occurs predominantly as a pentamer. Polymerization is through the Fc portion of the molecule facilitated by an additional polypeptide, the J-chain.
Immunoglobulins are synthesized by cells of the B-lymphocyte line. These arise from multipotential stem cells originating in the yolk sac, then migrating to fetal liver and bone marrow, and in the adult are found mainly in bone marrow.
The earliest detectable immunoglobulin synthesis is in pre-B cells which show cytoplasmic jichains, indicating that heavy chain synthesis has been switched on, but lacking surface or secreted immunoglobulin.
The clonal secretion theory of antibody formation (Burnet 1959 , Jerne 1971 postulates that an immunologically responsive B-cell will only respond to a single antigen. The role of antigen is to react with the precommitted cell, resulting in its proliferation and the generation of a clone of differentiated antibody-forming cells. The response of an individual is thus a sum of the responses of all the different lymphocytes he contains.
The structure of the immunoglobulin molecule, with a highly variable and constant region, led to the Dreyer-Bennett hypothesis (Dreyer & Bennett 1965) , in which it was proposed that the genes for the variable and constant regions were encoded separately. Moreover, there are many variable region genes in the DNA of the germline but only one or a few constant region genes. This 'split gene' hypothesis received much criticism at the time, but later research using DNA hybridization and sequencing techniques indicated that it was essentially true. The variable region of the light chain, for example, is encoded in the germ-line by V and J sequences and the constant region by a C gene. The V segments are separated by a long non-coding stretch of DNA from the J sequences which are also separated by an intervening sequence from the C gene. The heavy chain genes are arranged in a similar basic pattern but with an additional unique segment, the D sequence. The number of possible antibodies an individual may produce, the contribution of genetic recombinations and the possible contribution of point mutations to an individual's total repertoire of possible antibody responses was considered by Dr M Weigert (Institute of Cancer Research, Philadelphia, USA).
An individual inherits a large number of gene segments coding for the variable region. In the mouse there are four joining (J) gene segments for the heavy chain variable region (VH) and four J gene segments for the major light chain variable region (Vk). The number of Vk and VH gene segments is estimated to be about 300 for each, and a complete V region gene is formed by recombination of V and J gene segments. Hence the inherited repertoire of antibody specificities results from the combinatorial joining of different Vk and Jk gene segments and different VH and JH gene segments (along with the additional segment, D, unique to the VH region); and the combinatorial association of different VH and VL regions. Thus the inherited repertoire is in the order of 105 to 106 different specificities.
The potential repertoire of an individual for a single antigenic determinant such as the hapten iodonitrophenacetyl (Kreth & Williamson 1973) or the haemagglutinin (HA) molecule of the influenza virus (Standt & Gerhard 1984) has been calculated to be far greater than 103. Assuming that there must be at least 104 different antigens, these findings argue that the potential repertoire is at least 10-fold higher than that inherited by the individual.
To investigate possible mechanisms that could contribute to antibody diversity, Dr Weigert's group have initiated an analysis of the structure of the antibodies (and their genes) that bind to the influenza HA molecule. The investigation has been concentrated on a set of antibodies produced by hybridomas generated from a single mouse. Antibodies of this set could be shown to be coded for by the same VH and VL genes yet demonstrated a range of different fine specificities for the influenza HA molecule. By analysing the V regions of these hybridoma antibodies at both the protein and DNA level, various mechanisms for generating diversity are suggested. One mechanism appears to be recombination between different VH genes but, in addition, comparison of antibodies derived from a single mouse indicates that somatic mutations may contribute substantially to variability, which results mainly from single base changes, but these occur continuously thereby leading to a sequential accumulation of mutations, and finally the rate of mutation is high (the present estimate is about 10 3/base pair/generation). The reason for this high rate of mutation is unknown. Preliminary analysis suggests that mutations occur mainly in and around V region genes after the gene segments have recombined. It has been shown that the high mutation rate is not a feature of the V region gene nor a consequence of the process of V gene recombination, but rather that the high rate of mutation is conferred to the V region by DNA near constant region genes (McKean, Huppi and Weigert, in preparation) .
Not only is the mature B-lymphocyte committed to the expression of a specific antigenbinding site, as has been discussed, but also to expression of constant region genes, i.e. heavy chain class and subclass and light chain type. Immunoglobulin may be synthesized as an effector molecule, secreted from the cell, or as a surface marker on the B-lymphocyte which acts as receptor for antigen, the antigen acting to trigger the cell. The cellular events and control mechanisms for expression of immunoglobulin genes (Cushley & Williamson 1982) in stages of differentiation of the B-lymphocyte were considered by Dr A R Williamson (Glaxo Group Research Ltd, Greenford, Middlesex).
The genes for the heavy chains and for each of the light chains are encoded on different chromosomes. Each somatic cell has two sets of chromosomes, one member of each chromosome pair inherited from the mother and the other from the father. The stem cell thus has 6 chromosomes with genetic information for immunoglobulin synthesis. In the mouse these are chromosome pairs 12,6 and 16. By a process of DNA recombination and RNA splicing, the final differentiated cell in the B-lymphocyte series will express functionally one H and one L chain gene in an integrated form.
The first event in differentiation involves recombination of the DNA coding for the heavy chain. A single variable region (formed from V/D/J recombination) is brought into proximity of the constant region genes. Some noninformational DNA remains between the genes. The DNA recombination events are precisely controlled by two pairs of complementary recognition sequences, of 7 and 10 base pairs. The spacing of these recognition sequences by 11 or 22 base pairs seems to be fundamental for recombination, which takes place only when one of the two complementary signals has the short spacer and the other signal has a long spacer.
The first RNA transcript from the recombined DNA also includes non-informational sequences but only one VH and the CH sequence. The RNA is then spliced and the VH and CH genes joined to form m-RNA which is transcribed into a colinear, contiguous p-chain. At that stage the The next event is a similar recombination event to bring the VL gene in proximity to the CL gene. Only one light chain type is ever synthesized by a committed B-cell clone; how this is selected will be discussed later.
The synthesis of p-chain and light chain produces an immunoglobulin of the IgM class which is found firstly on the surface of the cell. Surface immunoglobulin allows antigen recogniton and further cellular differentiation.
Once DNA recombination has occurred the Bcell is committed to light chain type and to heavy chain variable region; the antibody specificity therefore does not change. However, within the life of a B-lymphocyte clone the expression of heavy chain constant region may alter from IgM through IgD to IgG, IgE and IgAthe so called 'class switch'. Immunoglobulin may also be membrane-bound or secreted.
A single gene codes for the p-chain of both the secreted and the membrane protein. The proteins differ in the amino acid sequence, the tail (T) region, beyond the last homology region in the Fc part of the molecule (C4). The T-secretor consists of some 20 amino acid residues and is hydrophilic. The T-secretor (Ts) DNA sequence is contiguous with the constant region sequences. T-membrane (Tm) consists of 40 amino acids with a core of 26 hydrophobic residues which anchor the molecule into the membrane, and is coded for by two exons separated fom each other by 118 base pairs and from the Ts sequences by about 2000 base pairs. The expressed p-gene contains both the Ts and Tm membrane sequences. The sequence for either Tm or Ts is selected by RNA splicing.
The next event in B-lymphocyte development is the expression of surface IgD, together with surface IgM. The simultaneous expression of the two classes may also be explained in terms of RNA splicing. Transcription proceeds through the variable region and through the j gene, to yield a i chain. A second transcript continues for a few more thousand nucleotides and therefore includes not only V/D/J and p sequences but also the 5 genes. Among the options of splicing this transcript is to join V/D/J to the 5 gene. The switch to the other classes involves some DNA recombination. There are no further J chain segments, which probably accounts for the invariable first event of joining V/D/J to the p sequences.
During the selection of the heavy chain gene there is allelic exclusion. There seems to be no preference for the maternal or paternal gene.
However, in the joining of V/D/J and p there is a high error frequency. It is possible to detect in a functional B cell whether the genes are in the non-recombined state (zero gene H°), incorrectly rearranged (minus gene H ) or correctly rearranged and functionally transcribed (plus gene H+). Some 90% of cells synthesizing immunoglobulin are in the H-/H+ form, indicating that there was an error in the first joining and the second chromosome had subsequently to be arranged. The other 10% of cells have the H°/H+ configuration. This high rate of error would indicate that in some cells there should be error in joining events on both chromosomes: such a cell would inevitably be non-functional.
Selection of light chain allele again seems to show no preference for maternal or paternal chromosome. However, it appears that the kappa chain genes are recombined in preference to the lambda. Lambda is only transcribed if there is an error in both kappa chain recombinational events. The error rate of light chain recombinations is less than that of the heavy chain, some 50% of immunoglobulin synthesizing cells having the K-/K+ configuration and 50% the KO/K+.
Recent work on allelic variants in the rabbit would appear to defeat conventional genetics. In the rabbit there appear to be three allelic forms of the V-genes. However, these cannot be true alleles since all three can be expressed in the same animal with very low production of one allele (although this same allele may be fully expressed in a different animal). This very low production is also seen in the pre-B cell, indicating that there is not equal expression of all three alleles and then selection. There must be some fundamental difference in expression indicating another level of control, as yet not understood.
The synthesis of J-chain, found in polymerized immunoglobulins, occurs only in activated cells. The J-chain (which should not be confused with the J gene segments) is a protein of MW 15 000, heavily glycosylated, and not found in early B or pre-B cells. The DNA coding for the J-chain is heavily methylated, and only transcribed in the activated cell.
The organization of the immunoglobulin genes in the human and the evidence for human immunoglobulin genes being unstable genetic regions was discussed by Dr T Rabbitts (MRC Laboratory of Molecular Biology, Cambridge) in the final paper of the meeting.
Human light chain genes are coded for on chromosome 22 (lambda) and chromosome 2 (kappa), and the heavy chain genes on chromosome 14. The five heavy chain classes previously discussed are all found in the human. IgG occurs as four sub-classes (yj, Y2 y3, y4) and IgA as two sub-classes (a,, a2) all coded for in the constant region genes. The organization of the H-chain in man differs from that described for the mouse in some dramatic ways in the ordering of CH genes. Downstream from the VH and D region there are six J-segments (with an additional pseudo Jsegment between Ji and J2 which is analogous but defective), and then constant region gene segments in the order t, 6, Y3, yV, pseudo-£1, ao, Y2, Y4, e and finally (X2. The origin of the gene duplications in man, i.e. y-y-s-a, is interesting evolutionarily, and may have occurred by one of two mechanisms. In evolution the earliest finding would be single heavy gene segments for y, E and a. Duplication of y would give rise to y-y-e-a, and then duplication of the whole region with evolutionary mutational drift could give rise to the pattern seen in man. Alternatively, the basic y-e-a sequence may have been duplicated, followed by further duplication in each gamma region. In man Y3 and yi sequences are very similar, as are Y2 and Y4, which would argue for the latter proposed mechanism. However, in the mouse there is only one gene for e and a with four gamma sequences linked upstream in one block, which would support y duplication being an early evolutionary event.
The pseudo-E1 gene is a germ-line gene presumably present in all normal humans, although only 6 individuals have so far been investigated; it has extensive coding segment deletion and is therefore not translated into protein.
The understanding of the organization of the human heavy chain genes may help in understanding some of the complex patterns of immunoglobulin deficiency in man. For example, a Tunisian studied by Dr Rabbitts was found to be deficient for IgGI, 2 and 4 and IgAl, to have normal levels of IgM, IgA2, IgD and IgE and raised levels of IgG3. Southern blot analysis (Southern 1975 ) indicated germ-line deletion of the genes coding for all those immunoglobulins deficient in the patient (together with pseudo-£1).
Looking back to the sequence of genes in the human, it is clearly possible to see how this arises by deletion of all sequences downstream from the Y3 sequence and upstream from the E sequence.
These findings suggest a certain genetic instability which may be inherent in the structure of the non-informational DNA associated with the heavy chain constant region genes. Within the DNA, between the VH and first C. gene segment, there occurs a stretch of some 2000 base pairs which includes a series of repeated nucelotides. Similar sequences of repeated blocks can be demonstrated adjacent to the alpha, epsilon and gamma genes and these apparently serve as switch signals to join V/D/J to heavy chain constant regions in class switching. These may also provide vulnerable sites for germ-line genetic deletions.
Chromosomes of tumour cells often undergo translocations, that is exchange of material between different chromosomes. In Burkitt's lymphoma and chronic myeloid leukaemia (CML), translocations with the chromosomes containing immunoglobulin genes are involved. In Burkitt's lymphoma 90% of cell lines have translocations of chromosome 14 with chromosome 8. The remaining 10% have translocations of chromosome 2 or 22, again with chromosome 8. In CML the translocation involves chromosome 9 with 22, resulting in the appearance of the Philadelphia chromosome. The translocation points appear to be very close or within the immunoglobulin gene segments.
Finally, the consequence of translocations of immunoglobulin coding sequences was discussed with reference to oncogenes. Oncogenes are DNA sequences (c-onc) showing homology to viral oncogenes (v-onc) in RNA tumour viruses.
The c-onc genes are expressed in cells, presumably as normal cell products. Increased activity of such genes has been proposed as a mechanism of neoplastic transformation. One mechanism of activating such genes would be to bring an active promotor into the immediate neighbourhood of a c-onc gene by chromosomal translocation.
In man the c-abl gene, which is homologous to the Abelson murine leukaemia virus oncogene, is located on chromosome 9. As discussed above this is the chromosome that is involved in translocations with chromosome 22, and the appearance of the Philadelphia chromosome in human CML. An important consideration of the 9/22 translocations is the fate of the A light chain genes on chromosome 22 and the c-abl geme of chromosome 9. It is possible to investigate this with somatic cell hybrids. Chinese hamster ovary cells are fused with blast cells from CML patients. Segregants are then derived which carry only one of the translocated chromosomes, i.e. the shortened chromosome 22 (22q-: the Philadelphia chromosome) or the lengthened chromosome 9 (9q+). Using the technique of Southern blotting, restriction-endonuclease-treated DNA from such segregants may be analysed with a mouse v-abl probe. The 9q+ segregants investigated do not carry the c-abl gene. Both the A genes and c-abl genes are located in the cell lines carrying the 22q-chromosome, indicating that the c) and c-abl genes become linked in the Philadelphia chromosome. There may be a presumptive effect on formation of the tumour, but at the present time the relationship between tumorigenesis and chromosomal translocations in CML is not known.
Chromosome 8, which is translocated to one of three chromosomes in human B-cell lymphoma lines derived from Btirkitt's lymphoma, also carries an oncogene. This is the c-myc gene and is homologous to the avian myelocytomatosis virus transforming gene. Using similar techniques to those described to investigate the CML hybrids, and using an avian v-myc probe, it seems that in lines with 8/14 translocations, the exact crossover point may vary but in most cases the translocation recombines c-myc with heavy chain immunoglobulin genes (the 14q+ chromosome).
The consequence of the translocation of c-myc into the immunoglobulin locus has been investigated by estimations of the level of RNA transcription, and there is evidence for high cmyc RNA at least in the 14q+ lines used. Clearly, both translocations and high c-myc m-RNA synthesis must be relevant in these lymphoma lines, but whether one is consequential upon the other or to production of the tumour remains to be demonstrated.
This short meeting illustrated wonderfully how increasing knowledge of the control of antibody production has indeed challenged genetic dogma and that it is by no means over, with more challenges to come. PAMELA G RICHES Protein Reference Unit Westminster Hospital Medical School, London
